Fresenius SE & Co. KGaA (ETR:FRE)
40.01
+0.01 (0.03%)
Mar 28, 2025, 5:35 PM CET
Fresenius SE & Co. KGaA Employees
Fresenius SE & Co. KGaA had 193,865 employees as of December 31, 2023. The number of employees decreased by 123,055 or -38.83% compared to the previous year.
Employees
193,865
Change (1Y)
-123,055
Growth (1Y)
-38.83%
Revenue / Employee
€123,710
Profits / Employee
€2,669
Market Cap
22.53B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 193,865 | -123,055 | -38.83% |
Dec 31, 2022 | 316,920 | 842 | 0.27% |
Dec 31, 2021 | 316,078 | 4,809 | 1.54% |
Dec 31, 2020 | 311,269 | 17,135 | 5.83% |
Dec 31, 2019 | 294,134 | 17,384 | 6.28% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 90,587 |
Sartorius Aktiengesellschaft | 13,528 |
Fresenius Medical Care AG | 111,513 |
Carl Zeiss Meditec AG | 5,730 |
Fielmann Group AG | 23,412 |
SCHOTT Pharma AG & Co. KGaA | 4,690 |
Fresenius SE & Co. KGaA News
- 2 days ago - Fresenius gets FDA approval for biosimilars of Amgen's bone-condition drugs - Seeking Alpha
- 12 days ago - Fresenius: Turnaround For Company, Stock Price - Seeking Alpha
- 23 days ago - Health Care Roundup: Market Talk - The Wall Street Journal
- 25 days ago - EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius announces its intention to reduce its stake in Fresenius Medical Care AG from currently around 32.2% to no less than 25% plus one share - Wallstreet:Online
- 4 weeks ago - Fresenius SE & Co KGaA (FSNUF) Full Year 2024 Earnings Call Highlights: Strong Growth and ... - GuruFocus
- 4 weeks ago - Fresenius SE & Co. KGaA 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 4 weeks ago - Fresenius SE & Co. KGaA (FSNUF) Full Year and Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Germany has homework to do, Fresenius CEO says - CNBC